ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,942.47
      1.26%
      US Tech 100
      20,762.73
      1.73%
      Dow Jones
      42,732.13
      0.80%
      Brent Oil
      76.495
      0.00%
      Bitcoin
      98,314.43
      0.11%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Nextensa SA (NEXTA) Quote

      Nextensa SA

      Nextensa SA (NEXTA)

      EU
      43.60
      0.40
      (0.93%)
      Closed January 04 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      43.60
      Bid
      43.20
      Ask
      44.60
      Volume
      1,891
      43.60 Day's Range 44.65
      35.70 52 Week Range 50.20
      Market Cap
      436.087M
      Previous Close
      43.20
      Open
      43.80
      Last Trade
      27
      @
      43.6
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,449
      Shares Outstanding
      10,002,000
      Dividend Yield
      -
      PE Ratio
      17.81
      Earnings Per Share (EPS)
      2.45
      Revenue
      126.4M
      Net Profit
      24.49M

      About Nextensa SA

      Sector
      Real Estate Investment Trust
      Industry
      Real Estate Investment Trust
      Website
      www.nextensa.eu
      Headquarters
      Brussels, Brussels-capital Region, Bel
      Founded
      -
      Nextensa SA is listed in the Real Estate Investment Trust sector of the Euronext with ticker NEXTA. The last closing price for Nextensa was 43.20 €. Over the last year, Nextensa shares have traded in a share price range of 35.70 € to 50.20 €.

      Nextensa currently has 10,002,000 shares outstanding. The market capitalization of Nextensa is 432.09 € million. Nextensa has a price to earnings ratio (PE ratio) of 17.81.

      Ask ADVFN Intelligence (AI)

      NEXTA Latest News

      More News

      Nextensa annonce le succès de la vente du Brixton Retail Park à Zaventem, Belgique

      Nextensa annonce le succès de la vente du Brixton Retail Park à Zaventem, Belgique COMMUNIQUÉ DE PRESSE INFORMATION NON RÉGLEMENTÉEBruxelles, 16 décembre 2024, 07h30          Nextensa annonce...

      December 16 2024
      UK Regulatory

      Nextensa announces successful sale of Brixton Retail Park in Zaventem, Belgium

      Nextensa announces successful sale of Brixton Retail Park in Zaventem, Belgium PRESS RELEASE NON-REGULATED INFORMATIONBrussels, 16 December 2024, 5:40 PM Nextensa announces successful sale of...

      December 16 2024
      UK Regulatory

      Nextensa SA: Informations relatives au nombre total de droits de vote et d'actions

      Nextensa SA: Informations relatives au nombre total de droits de vote et d'actions COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉEBrussels, 28 novembre 2024, 17h40          Nextensa SA...

      November 28 2024
      UK Regulatory

      Nextensa NV/SA : Information on the total number of voting rights and shares

      Nextensa NV/SA : Information on the total number of voting rights and shares PRESS RELEASE REGULATED INFORMATIONBrussels, 28 November 2024, 5:40 PM          Nextensa NV/SA : Information on the...

      November 28 2024
      UK Regulatory

      Nextensa: RÉSULTATS Q3 2024

      Nextensa: RÉSULTATS Q3 2024 INFORMATION RÉGLEMENTÉE Bruxelles, 14 novembre 2024, 17h40 RÉSULTATS Q3 2024 FAITS MARQUANTS IMMEUBLES DE PLACEMENT Les revenus locatifs sont supérieurs de 750K €...

      November 14 2024
      UK Regulatory

      Nextensa: Q3 RESULTS 2024

      Nextensa: Q3 RESULTS 2024 REGULATED INFORMATION Brussels, 14 November 2024, 5:40 PM Q3 RESULTS 2024 HIGHLIGHTS  INVESTMENT PROPERTIES The rental income is €750K higher than in the third...

      November 14 2024
      UK Regulatory

      Nextensa: HALF YEAR RESULTS 2024

      Nextensa: HALF YEAR RESULTS 2024 REGULATED INFORMATIONBrussels, 13 August 2024, 5:40 PM HALF YEAR RESULTS 2024 HIGHLIGHTS DEVELOPMENT PROJECTS• A binding sales agreement was signed in early August...

      August 13 2024
      UK Regulatory

      Nextensa: RESULTATS SEMESTRIELS 2024

      Nextensa: RESULTATS SEMESTRIELS 2024 INFORMATION RÉGLEMENTÉEBruxelles, 13 août 2024, 17h40 RÉSULTATS SEMESTRIELS 2024 FAITS MARQUANTS PROJETS DE DÉVELOPPEMENT• Début août, un contrat de vente...

      August 13 2024
      UK Regulatory

      Nextensa : Informations relatives au nombre total de droits de vote et d'actions

      Nextensa : Informations relatives au nombre total de droits de vote et d'actions COMMUNIQUÉ DE PRESSE INFORMATION RÉGLEMENTÉEBruxelles, 12 juin 2024 07h30 Nextensa SA: Informations...

      June 12 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      11.63.809523809524244.6541.55116942.30520967DE
      44.712.082262210838.944.6535.7227439.04903399DE
      121.152.7090694935242.4544.6535.7144940.2602206DE
      26-0.4-0.9090909090914445.1535.7129741.7480323DE
      52-5.8-11.740890688349.450.235.7125943.57116262DE
      156-34.4-44.10256410267879.635.7236550.04414469DE
      260-28.8-39.779005524972.479.635.7236850.77663785DE

      NEXTA - Frequently Asked Questions (FAQ)

      What is the current Nextensa share price?
      The current share price of Nextensa is 43.60 €
      How many Nextensa shares are in issue?
      Nextensa has 10,002,000 shares in issue
      What is the market cap of Nextensa?
      The market capitalisation of Nextensa is EUR 432.09M
      What is the 1 year trading range for Nextensa share price?
      Nextensa has traded in the range of 35.70 € to 50.20 € during the past year
      What is the PE ratio of Nextensa?
      The price to earnings ratio of Nextensa is 17.81
      What is the cash to sales ratio of Nextensa?
      The cash to sales ratio of Nextensa is 3.45
      What is the reporting currency for Nextensa?
      Nextensa reports financial results in EUR
      What is the latest annual turnover for Nextensa?
      The latest annual turnover of Nextensa is EUR 126.4M
      What is the latest annual profit for Nextensa?
      The latest annual profit of Nextensa is EUR 24.49M
      What is the registered address of Nextensa?
      The registered address for Nextensa is GARE MARITIME , 11 RUE PICARD B505, BRUSSELS, BRUSSELS-CAPITAL REGION, BE-1000
      What is the Nextensa website address?
      The website address for Nextensa is www.nextensa.eu
      Which industry sector does Nextensa operate in?
      Nextensa operates in the REAL ESTATE INVESTMENT TRUST sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MLFXOFinaxo
      0.895 €
      (43.20%)
      		500
      MLWEYWeya
      0.0175 €
      (34.62%)
      		5.1k
      POXELPoxel
      0.191 €
      (33.57%)
      		4.22M
      ALBIOBiosynex
      2.50 €
      (28.73%)
      		50.71k
      SEQUASequana medical NV
      3.02 €
      (23.27%)
      		1.05M
      BNBSTonner Drones
      0.0005 €
      (-50.00%)
      		524.03k
      ALAGOEPango SA
      0.127 €
      (-41.20%)
      		11.94M
      EIFDSTour Eiffel DS
      0.0032 €
      (-38.46%)
      		33.94k
      FINMFinanciere Marjos
      0.076 €
      (-36.13%)
      		1.4k
      ALALOAcheterLouerFR
      0.20 €
      (-33.33%)
      		90.63k
      ATOAtos SE
      0.0024 €
      (-4.00%)
      		1.53B
      BCPBanco Comercial Portugues SA
      0.4623 €
      (0.74%)
      		43.69M
      ALTDTonner Drones
      0.0118 €
      (-7.81%)
      		27.49M
      NEOENNeoen SA
      39.74 €
      (-0.15%)
      		21.76M
      ALVERVergnet
      0.002 €
      (0.00%)
      		16.8M

      Discussion

      View Full Feed
      elks elks 5 minutes ago
      Wtf.
      TWOH
      fuagf fuagf 6 minutes ago
      Security risk? Shrug. Trump flips on Tik Tok, because it's good for him.

      PatriotTakes 🇺🇸
      @patriottakes
      Nikki Haley comes out against Trump’s plan to save TikTok, but won’t mention him by name

      https://pbs.twimg.com/media/GgeV_fjXkAAgNe7?form
      XMaster2023 XMaster2023 7 minutes ago
      Roman, there could already be deals cut and the only thing we are waiting for now is approval. I actually believe this is the case and NWBO is under a gag order as BP would not want anything getting out until approval.
      NWBO
      JJ8 JJ8 9 minutes ago
      I am encouraged of what I see of the Histogram in the Weekly Chart showing that a new uptrend appears to be in the process of developing for the AMD share price.

      Hopefully that is going to continue... and lead to a share price breakout soon.

      We shall see.
      AMD
      boi568 boi568 10 minutes ago
      Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months. They may also have understandably diverted some resources towards a successful MAA.
      AVXL
      boi568 boi568 12 minutes ago
      There is no regulatory "sufficiency" test, other than being better than the standard of care, if one exists. The article makes the case that blarcamesine is better than any approved AD drug. The FDA employs a risk/benefit analysis, and you want your drug candidate to more than offset any risks with
      AVXL
      benz280c benz280c 12 minutes ago
      Changing the innards of a Chevy with Ferrari parts is a game changer. Learn about the Z06. Maybe you will appreciate what is set to occur when the cusip, name, and ticker changes in this instance. Ignorance is alive and well by folks old enough to know better. Sad!
      https://www.detroitnews.com
      GDVM
      flipper44 flipper44 14 minutes ago
      Do you happen to have a link to that example you gave?
      NWBO
      ty3 ty3 15 minutes ago
      Is that the company claiming to make water from air lol ? I think I posted a lol awhile back.
      CGAC
      OMOLIVES OMOLIVES 17 minutes ago
      Sorry to go off tilt..it's your fault. last one........killer:

      https://www.youtube.com/watch?v=wwIJk0C0xY0
      DiamondHealer95 DiamondHealer95 18 minutes ago
      I remember a time when dimes and mojo were wildly praised for their claim that this stock would hit $1-$3 by June. Just like Robert Sullivan on their Facebook page.

      It didn't.

      Stop considering their posts. They know next to nothing.

      By the way mojo - yo
      KBLB
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 19 minutes ago
      which position will the EMA take? (conventional), or will they go outside the box and follow in the steps of the authors, making the MABs relevant to the decision. The EMA has hinted that they are not happy with the MABs. The question might be, will the EMA approve a drug that can show partial pos
      AVXL
      BDEZ BDEZ 19 minutes ago
      A thug not even born here...smh.
      Huggy Bear Huggy Bear 20 minutes ago
      Actually that's Smokey Robinson, of the baby boomer generation, but what's an education worth nowadays?
      HMBL
      3331 3331 20 minutes ago
      OTC is entering a golden age in 2025 - Chartmaster.

      With news, BIEL could lead the way!
      BIEL
      skitahoe skitahoe 20 minutes ago
      While I know nothing about the specific trial, as I see it if the regulators accept the protocol of a specific trial they're also accepting the fact that if results warrant, they'll approve the drugs in the trial. It's up to the company to establish the acceptance criteria, which the regulator acce
      NWBO
      boi568 boi568 21 minutes ago
      The regulatory authorities don't care who is speaking at a conference, they just care what is submitted as part of a drug application.

      BTW, I happen to think personal testimony is a gimmick that will not impress cynical executives.
      AVXL
      Acme Investments Acme Investments 25 minutes ago
      People just don't understand how the Otc works!! If they say it runs it runs!! Doesn't matter if you like the fundamentals!!
      AITX
      DiamondHealer95 DiamondHealer95 25 minutes ago
      There it is! The MONDAY COULD BE EXCITING for the 457th time in 13 months!

      85%+ Monday PR releases and this user is betting on an update at anytime (no shit) and is picking... MONDAY!

      That folks is what we call a sure bet and staying the obvious.

      That bei
      KBLB
      SSKILLZ1 SSKILLZ1 25 minutes ago
      Pick 4 Contest #21 Contest Info. In.

      Hope everyone enjoys. Hope this helps.

      https://investorshub.advfn.com/Pick-4-Contest-No-21-46064
      SSKILLZ1 SSKILLZ1 26 minutes ago
      Pick 4 Contest #21 Contest Info. In.

      Hope everyone enjoys. Hope this helps.

      https://investorshub.advfn.com/Pick-4-Contest-No-21-46064
      Bob1968 Bob1968 26 minutes ago
      Interview with Intel CEO

      https://www.youtube.com/watch?v=DpJqRHFYUqk
      INTC
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 26 minutes ago
      I just bought a beautiful sporty looking SUV and it cost me almost 50K come on avxl I'm counting on you I got to get that money back LOL

      Same here with the red 'Stang. Let's make some cash!
      AVXL
      mrfence mrfence 27 minutes ago
      Don't let the paid shills fluster yah. Just know when they come at yah it's because you're speaking valid truth. That threatens their failing ruse. Oh, and thanks to JPS lawyers for making the case for commons while trying to rob them a second time :-D

      Your Recent History

      EU
      NEXTA
      Nextensa
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads